ELZA CEO, Nikki Hafezi: Ophthalmic Innovation Section Editor
Nikki Hafezi MAS IP ETHZ, the CEO of the ELZA Institute in Zurich, continues to drive innovation in the field of ophthalmology. As the newly
Mark Hillen
March 29, 2023
Nikki Hafezi MAS IP ETHZ, the CEO of the ELZA Institute in Zurich, continues to drive innovation in the field of ophthalmology. As the newly
His keynote lecture, in particular, provided insight into the latest advancements in treating corneas that are less than 400 microns thick – and potentially as low as 200 microns, using the sub400 protocol.
The success of SMILE procedures depends not only on the expertise of the surgeon but also on the ability to correct any complications that may arise. Prof. Hafezi’s article provides insight into the various approaches available for repairing failed SMILE procedures. Corneal wavefront-guided transPRK stands out as a method that offers significant advantages, including improving the corneal biomechanics and avoiding postoperative ectasia.
Prof. Farhad Hafezi, MD, PhD, FARVO, a prominent Swiss eye surgeon and researcher, has been awarded the title of “KOL Influencer 2023” by Media Mice,
Our Chief Executive Officer, Nikki Hafezi MAS IP ETHZ, last week gave a guest lecture at the Pompea College of Business at the University of New Haven, Connecticut, USA.
Postgraduate students currently studying the fundamentals of Multinational Management were able to benefit from Mrs. Hafezi’s experience across several sectors of business, including the medical device firm, EMAGine AG, a leading Swiss eye-care centre, the ELZA Institute, and the charitable organization, the Light for Sight Foundation.
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).
A recent study has identified the most cited articles and authors in refractive surgery using the Scopus database and a publicly available database of over 100,000 scientists. The study provides a comprehensive analysis of the most highly cited articles and authors in refractive surgery, shedding light on the significant contributions of researchers and physicians to the field. ELZA’s Medical Director, Prof. Farhad Hafezi, was one of the top 100 cited authors. Find out more about the study and the top contributors in refractive surgery.
The Smartphone-Based Keratographer (SBK) is a SMART method of performing early keratoconus detection: an app, headrest and a Placido disk attachment can lower cost and bring keratoconus screening to millions of people in developing countries who currently are not screened, thanks to cost and access reasons.
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News (OSN), where he spoke about advancing CXL technology for the treatment of corneal ectasias like keratoconus. The interview covered three main topics.
Léonard Kollros is the lead Optometrist at the ELZA Institute, and this month, a paper he authored was published in the Journal Français d’Ophtalmologie. It
